Impact of Hepatic Steatosis on the Antiviral Effects of PEG-IFNα-2a in Patients with Chronic Hepatitis B and the Associated Mechanism

OBJECTIVE: To investigate the risk factors for hepatic steatosis in chronic hepatitis B (CHB), to determine its correlation with liver necroinflammation and fibrosis and response to peginterferon alpha-2a (PEG-IFNα-2a) antiviral therapy, and to explore the mechanisms underlying the poor antiviral ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Huiqing, Liu, Yaoyu, Jiang, Xiaoqian, Zheng, Xiaoting, Tang, Jinmo, Yang, Jiaen, Zhuang, Hongli, Lai, Penghua, Peng, Li, Guo, Zhenying, Cai, Shanshan, Luo, Dan, Xu, Lingxia, Mao, Qianguo, Chen, Shaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335408/
https://www.ncbi.nlm.nih.gov/pubmed/32676103
http://dx.doi.org/10.1155/2020/1794769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335408/
https://www.ncbi.nlm.nih.gov/pubmed/32676103
http://dx.doi.org/10.1155/2020/1794769

Ejemplares similares